Arecor Therapeutics (AREC) Competitors GBX 75 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines AREC vs. FUM, MPH, ORPH, REDX, ETX, SBTX, TRX, POLB, COS, and C4XDShould you be buying Arecor Therapeutics stock or one of its competitors? The main competitors of Arecor Therapeutics include Futura Medical (FUM), Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), Tissue Regenix Group (TRX), Poolbeg Pharma (POLB), Collagen Solutions plc (COS.L) (COS), and C4X Discovery (C4XD). These companies are all part of the "biotechnology" industry. Arecor Therapeutics vs. Futura Medical Mereo BioPharma Group plc (MPH.L) Open Orphan Redx Pharma e-therapeutics SkinBioTherapeutics Tissue Regenix Group Poolbeg Pharma Collagen Solutions plc (COS.L) C4X Discovery Arecor Therapeutics (LON:AREC) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership. Which has higher earnings and valuation, AREC or FUM? Futura Medical has higher revenue and earnings than Arecor Therapeutics. Futura Medical is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArecor Therapeutics£4.90M5.78-£8.67M-£0.28-267.86Futura Medical£8.40M13.28-£3.75M-£0.01-3,687.50 Does the media favor AREC or FUM? In the previous week, Futura Medical had 1 more articles in the media than Arecor Therapeutics. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Arecor Therapeutics. Futura Medical's average media sentiment score of 0.67 beat Arecor Therapeutics' score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media. Company Overall Sentiment Arecor Therapeutics Neutral Futura Medical Positive Which has more risk & volatility, AREC or FUM? Arecor Therapeutics has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Does the MarketBeat Community prefer AREC or FUM? Futura Medical received 186 more outperform votes than Arecor Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformArecor TherapeuticsN/AN/AFutura MedicalOutperform Votes18664.36% Underperform Votes10335.64% Do analysts rate AREC or FUM? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arecor Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AFutura Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do institutionals & insiders believe in AREC or FUM? 44.1% of Arecor Therapeutics shares are owned by institutional investors. Comparatively, 35.7% of Futura Medical shares are owned by institutional investors. 25.3% of Arecor Therapeutics shares are owned by company insiders. Comparatively, 32.1% of Futura Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is AREC or FUM more profitable? Futura Medical has a net margin of -44.68% compared to Arecor Therapeutics' net margin of -176.89%. Futura Medical's return on equity of -47.43% beat Arecor Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Arecor Therapeutics-176.89% -94.76% -37.31% Futura Medical -44.68%-47.43%-26.59% SummaryFutura Medical beats Arecor Therapeutics on 12 of the 14 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AREC vs. The Competition Export to ExcelMetricArecor TherapeuticsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£28.32M£158.40M£5.40B£1.63BDividend YieldN/A3.39%5.16%11.03%P/E Ratio-267.86348.23113.091,785.79Price / Sales5.7819,806.471,478.84237,189.75Price / Cash5.0711.3039.8336.67Price / Book4.417.514.642.88Net Income-£8.67M-£18.90M£119.13M£148.87M7 Day Performance-2.60%-0.05%0.78%0.11%1 Month Performance18.32%2.54%5.66%-0.11%1 Year Performance-60.53%28.85%36.92%15.75% Arecor Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARECArecor TherapeuticsN/AGBX 75flatN/A-59.5%£28.32M£4.90M-267.8610Gap UpFUMFutura MedicalN/AGBX 35.98-6.9%N/A+28.8%£108.81M£8.40M-3,598.1012News CoverageGap UpMPHMereo BioPharma Group plc (MPH.L)N/AGBX 26.50-1.9%N/A+0.0%£89.76MN/A-0.2150Gap DownORPHOpen OrphanN/AGBX 10+5.3%N/AN/A£67.09M£34.71M-25.30179REDXRedx PharmaN/AGBX 15+31.6%N/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AGBX 9-6.7%N/A-2.6%£52.59M£295,000.00-450.0035News CoverageHigh Trading VolumeSBTXSkinBioTherapeuticsN/AGBX 18-2.7%N/A-40.4%£40.70M£21,949.00-900.0011High Trading VolumeTRXTissue Regenix GroupN/AGBX 54.05+2.0%N/A+7.9%£38.50M£31.80M-5,405.00120Gap DownPOLBPoolbeg PharmaN/AGBX 7.69-2.7%N/A+27.7%£38.44MN/A-768.8012Gap UpCOSCollagen Solutions plc (COS.L)N/AGBX 6.63flatN/A+0.0%£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading Volume Related Companies and Tools Related Companies Futura Medical Alternatives Mereo BioPharma Group plc (MPH.L) Alternatives Open Orphan Alternatives Redx Pharma Alternatives e-therapeutics Alternatives SkinBioTherapeutics Alternatives Tissue Regenix Group Alternatives Poolbeg Pharma Alternatives Collagen Solutions plc (COS.L) Alternatives C4X Discovery Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:AREC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
